Allergan, Inc.

Allergan Sales, Inc.

Jenivision Inc.

Arizona Board of Regents, a Body Corporate

David Frederick Woodward

Robert M Burk

Jenny W Wang

Jose L Martos

Jussi J Kangasmetsa

William Robert Carling

Ming Fai Chan

Michael E Garst

June Chen

Achim H Krauss

Amanda M VanDenburgh

Steven Wade Andrews

Achim H-p Krauss

Gyorgy F Ambrus

Weizhen Wang

Neil J Poloso

Alexander B Kharlamb

Patrick Michael Hughes

Daniel W Gil

Yariv Donde

Michael R Robinson

Danny Thang Dinh

Jinping Wan

Todd S Gac

Ke Wu

Yanbin Liang

Jie Shen

Hui Liu

John W Regan

Chandrasekar Durairaj

Charles Gluchowski

Mark Holoboski

Michael B Roof

Steven Dabbs

David W Old

Larry Allen Wheeler

Scott M Whitcup

Simon Neil Pettit

Mari F Posner

Hans G Fliri

Kenneth J Himmelstein

Elizabeth T Syage

Clive L Cornell

Linda C Smith-Thomas

Linda Sue Williams

Amelia L Nieves

Helen H Usansky

Cherukury Madhu

Clayton S Spada

Licheng Shi

Sheila Mac Neil

Ming Ni

Julia Herrmann

Amanda M Van Denburgh

William C Carling

The present invention is directed to compositions and formulations for hair growth. The non-aqueous, preservative-free formulations are useful for the growth of hair, eyebrows and eyelash in a variety of setting. Also provided herein are non-aqueous, preservative-free formulations and methods for the treatment of dry-eye and related symptoms.

Formulations for hair growth

The present invention relates generally to the use of compositions and methods for treating nociceptive events that occur on the ocular surface in association with dryness, injury, environmental pollutants, and infectious and non-infectious diseases. Specifically, the present invention is directed to the use of certain compounds for treating for treating ocular pain or ocular discomfort.

Use of prostacyclin antagonists for treating ocular surface nociception

The present invention provides a compound, that is a 1-({halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compound may be represented by the following formula Wherein R, R, R, RA, X, W, Z and Y are as defined in the specification. The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions.

Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response

The present invention is directed to compositions and methods for injection into fat deposits for sustained release of compounds which result in localized fat reduction.

Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction

Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.

Prostamide-containing intraocular implant

Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A, B, Z, X, Rand Rare as defined in the specification. Such compositions are used in treating the skin or scalp of a human or non-human animal. Bimatoprost is preferred for this treatment.

Method of enhancing hair growth

Disclosed herein are methods, compounds, and compositions for fat reduction, and in particular fat reduction without significant hair growth and/or additional hair growth.

Methods for fat reduction

New compositions for and methods of treating ocular hypertension provide for effective treatment of ocular hypertension often using reduced concentrations of active components. Such compositions include a timolol component and a hypotensive lipid component. The present compositions and methods are relatively straightforward, can be easily produced, for example, using conventional manufacturing techniques, and can be easily and conveniently practiced, for example, using application or administration techniques or methodologies which are substantially similar to those employed with prior compositions used to treat ocular hypertension.

Hypotensive lipid and timolol compositions and methods of using same

Disclosed herein are compositions comprising an amide related to a prostaglandin and a biogenic amine. Other aspects relate to certain chemical compounds, pharmaceutical compositions, and methods of treating glaucoma.

Prostamides for the treatment of glaucoma and related diseases

The present invention is directed methods of lowering intraocular pressure in a patient suffering from elevated intraocular pressure or glaucoma and treating ocular disease by administering a drug to the periorbital skin of the patient.

Quantitative peri-orbital application of ophthalmology drugs

Growing community of inventors

Lake Forest, CA, United States of America

David Frederick Woodward